We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

New Long-acting Contraceptive Designed to Be Self-administered

News   Jan 15, 2019 | Original story the Georgia Institute of Technology

 
New Long-acting Contraceptive Designed to Be Self-administered

Regents' Professor Mark Prausnitz holds an experimental microneedle contraceptive skin patch. Designed to be self-administered by women for long-acting contraception, the patch could provide a new family planning option. Credit: Christopher Moore, Georgia Tech

 
 
 

RELATED ARTICLES

First Generic Version of EpiPen Is Approved

News

The U.S. Food and Drug Administration has approved the first generic version of EpiPen and EpiPen Jr (epinephrine) auto-injector for the emergency treatment of allergic reactions, including those that are life-threatening (anaphylaxis), in adults and pediatric patients who weigh more than 33 pounds.

READ MORE

$1.7 Million Grant to Study Potential Skin Cancer Treatment

News

Ohio University scientists have been awarded a five-year $1.7 million grant to advance research on a potential prevention and treatment for non-melanoma skin cancers.

READ MORE

Team Design Drug Molecule to Improve Heart Attack Recovery

News

A new molecule has been developed that could help preserve heart tissue during – and even after – a heart attack.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE